Sanofi Portfolio Stock Holdings
Sanofi disclosed 10 stock positions valued at approximately $534.0 million in its latest SEC 13F filing. The largest holdings include Inhibrx Biosciences, Inc., Novavax, and AnaptysBio. The filing reflects positions held as of June 30, 2026 and was filed on July 28, 2026.
- Report Period
- June 30, 2026
- No. of Stocks
- 10
- Portfolio Value
- $534.0M
Holdings by Sector
Sanofi Portfolio Holdings in Q2 2026
5 holdings in the latest reporting period.
Page 1 of 1
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| Inhibrx Biosciences, Inc. | INBX | Healthcare | 20.54% | 1,157,926 | - | - | $109,713,489 |
| Novavax | NVAX | Healthcare | 12.14% | 6,880,481 | - | - | $64,814,131 |
| AnaptysBio | ANAB | Healthcare | 10.39% | 821,917 | - | - | $55,479,398 |
| Immuneering Corp | IMRX | Healthcare | 2.53% | 2,708,559 | - | - | $13,515,709 |
| Q32 Bio Inc. | QTTB | Healthcare | 0.58% | 244,083 | - | - | $3,109,617 |